Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
More news in Industry
LANXESS, BPCL join hands to develop next-gen lubricant solutions
Sanmar’s Vijay Sankar to lead FICCI in its centenary year
Victorinox targets 30% watch growth in India, plans ₹35,000 entry-level range
Adani Airports, IHCL plan 8 hotels with 2,000+ rooms across four cities, expanding airport-led hospitality hubs